Thrombospondin-1 treatment prevents growth of dormant lung micrometastases after surgical resection and curative radiation therapy of the primary tumor in human melanoma xenografts

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 2, 2004, Pages 493-499

  Rofstad, Einar K ^a   Galappathi, Kanthi ^a   Mathiesen, Berit ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiogenesis; Dormant micrometastases; Melanoma; Metastatic growth; Primary tumor eradication; Thrombospondin 1

Indexed keywords

BLOOD; CELLS; PULMONARY DISEASES; RADIOTHERAPY; TUMORS;

APOPTOSIS;

ONCOLOGY;

ANTINEOPLASTIC AGENT; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; EXPERIMENTAL MODEL; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG METASTASIS; LUNG RESECTION; MELANOMA; NONHUMAN; PRIORITY JOURNAL; STEREOMICROSCOPY; XENOGRAFT;

EID: 0942268140     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.030     Document Type: Conference Paper

References (32)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1989;4-6.
2. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
3. Ramanujan S., Koenig G.C., Padera T.P., Stoll B.R., Jain R.K. Local imbalance of proangiogenic and antiangiogenic factors A potential mechanism of focal necrosis and dormancy in tumors . Cancer Res. 60:2000;1442-1448.
4. Sugarbaker E.V., Thornthwaite J., Ketcham A.S. Inhibitory effect of a primary tumor on metastasis. Day S.B., Myers W.P.L., Stansly P. Progress in cancer research and therapy. 1977;227-240 Raven Press, New York.
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:1995;27-31.
6. Gohongi T., Fukumura D., Boucher Y., et al. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth Involvement of transforming growth factor β1 . Nat Med. 5:1999;1203-1208.
7. Volpert O.V., Lawler J., Bouck N.P. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci USA. 95:1998;6343-6348.
8. Hartford A.C., Gohongi T., Fukumura D., Jain R.K. Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site Potential role of host-tumor interaction . Cancer Res. 60:2000;2128-2131.
9. O'Reilly M.S., Holmgren L., Shing Y., et al. Angiostatin A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma . Cell. 79:1994;315-328.
10. Holmgren L., O'Reilly M.S., Folkman J. Dormancy of micrometastases Balanced proliferation and apoptosis in the presence of angiogenesis suppression . Nat Med. 1:1995;149-153.
11. Rofstad E.K., Graff B.A. Thrombospondin-1-mediated metastasis suppression by the primary tumor in human melanoma xenografts. J Invest Dermatol. 117:2001;1042-1049.
12. Camphausen K., Moses M.A., Beecken W.D., Khan M.K., Folkman J., O'Reilly M.S. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res. 61:2001;2207-2211.
13. Rofstad E.K., Halsør E.F. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res. 60:2000;4932-4938.
14. Bornstein P. Diversity of function is inherent in matricellular proteins An appraisal of thrombospondin 1 . J Cell Biol. 130:1995;506-530.
15. Rofstad E.K. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br J Cancer. 70:1994;804-812.
16. Rofstad E.K., Måseide K. Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points. Br J Cancer. 78:1998;892-898.
17. Danielsen T., Rofstad E.K. VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts. Int J Cancer. 76:1998;836-841.
18. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med. 6:2002;1-12.
19. Grant S.W., Kyshtoobayeva A.S., Kurosaki T., Jakowatz J., Fruehauf J.P. Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma. Cancer Detect Prev. 22:1998;185-194.
20. Grossfeld G.D., Ginsberg D.A., Stein J.P., et al. Thrombospondin-1 expression in bladder cancer Association with p53 alterations, tumor angiogenesis, and tumor progression . J Natl Cancer Inst. 89:1997;219-227.
21. Miyanaga K., Kato Y., Nakamura T., et al. Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Res. 22:2002;3941-3948.
22. Yamaguchi M., Sugio K., Ondo K., Yano T., Sugimachi K. Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer. Lung Cancer. 36:2002;143-150.
23. Rice A.J., Steward M.A., Quinn C.M. Thrombospondin-1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast. J Clin Pathol. 55:2002;921-925.
24. Kodama J., Hashimoto I., Seki N., et al. Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer Correlation with angiogenesis and prognosis . Clin Cancer Res. 7:2001;2826-2832.
25. Mehta R., Kyshtoobayeva A.S., Kurosaki T., et al. Independent association of angiogenesis index with outcome in prostate cancer. Clin Cancer Res. 7:2001;81-88.
26. Streit M., Velasco P., Brown L.F., et al. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol. 155:1999;441-452.
27. Jiménez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., Bouck N.P. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med. 6:2000;41-48.
28. Gorski D.H., Mauceri H.J., Salloum R.M., Halpern A., Seetharam S., Weichselbaum R.R. Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy. Cancer Res. 63:2003;308-311.
29. Dong Z., Kumar R., Yang X., Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 88:1997;801-810.
30. Rofstad E.K. Microenvironment-induced cancer metastasis. Int J Radiat Biol. 76:2000;589-605.
31. Gorski D.H., Beckett M.A., Jaskowiak N.T., et al. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 59:1999;3374-3378.
32. Gridley D.S., Loredo L.N., Slater J.D., et al. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev. 22:1998;20-29.